jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Review

How Generic Drugs are Registered in Europe, United Kingdom, Australia and New Zealand? - A Drug Regulatory Perspective

Sandeep DS1★, Lavanya YK1, Shailesh T2★ Corresponding author

  1. 1NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmaceutical Regulatory Affairs, Mangaluru, Karnataka, INDIA.
  2. 2Department of Pharmaceutics, JSS College of Pharmacy, Mysuru, JSS Academy of Higher Education and Research, Mysuru, Karnataka, INDIA.

CORRESPONDENCE

Sandeep DS

NITTE (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmaceutical Regulatory Affairs, Mangaluru, Karnataka, INDIA.

sandypharama@gmail.com

Received: 24-04-2023; Revised: 10-05-2023; Accepted: 26-05-2023.

Volume 13, Issue 3 · pp. 440–445 · PUBLISHED · DOI: 10.5530/ijpi.13.3.055

View on IJPI original site ↗

ABSTRACT

The present study describes the process of regulatory submission and generic drug registration in Europe, the UK, Australia, and New Zealand. The information and data for the compilation of the present review has been obtained from the relevant journals and from the official websites of respective drug regulatory authorities of Europe, the UK, Australia, and New Zealand. The generic drug approval process differs from one country to another. Europe follows multiple registration processes and the applicant decides the pathway based on the product category while the other three countries stick to a single registration process. All four countries follow the electronic CTD format for submitting the regulatory documents which allows the evaluation process more convenient and easier. The British Pharmacopoeia is a single reference guide for the quality control of medicines in all four countries under this study. From this study, it was concluded that in Europe and UK it takes about 12 months for dossier review for the approval of the generic drug. TGA of Australia takes approximately 11 months of timeline for generic drug approval whereas; MEDSAFE of New Zealand takes just 200 calendar days for generic drug registration which is quicker as compared to the other three countries.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    DS, S., YK, L., & T, S. (). How Generic Drugs are Registered in Europe, United Kingdom, Australia and New Zealand? - A Drug Regulatory Perspective. International Journal of Pharmaceutical Investigation, 13(3), 440–445. https://doi.org/10.5530/ijpi.13.3.055